ContraVir Pharmaceuticals, Inc. CTRV said Friday that its recent registration withdrawal was filed in error.
The ContraVir Pharma "RW" filing was made Thursday. The SEC RW filing is made by companies requesting to formally withdraw a pending securities registration.
ContraVir shares were down 10.98% at $9 at the time of publication Friday.
Related Links:
Why Low-Float, Thinly Traded ContraVir Pharma's Rally Is Continuing
Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
